These data suggested that CNTNAP4 KO demonstrate partial overlap in transcriptomic profiling with NELL1 gene deletion tumor cells, but that crucial differences in MAPK/FAK signaling and ECM expression profiles exist between the two KO transcriptomic phenotypes. This evidence concerns the gene NELL1 and neoplasm.